Day: November 8, 2022
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
- Allogeneic CAR T Program Updates Planned for Late Q4 2022 or Early Q1 2023 - Abstract Showcasing Functional Attributes of Azer-cel (PBCAR1091) Accepted for Presentation at the 64 th American Society of Hematology (ASH) Annual Meeting - Preclinical Research on In Vivo Gene Editing Programs